Bjerregaard, Caroline Løkke
Olsen, Flemming Javier
Skaarup, Kristoffer Grundtvig
Jørgensen, Peter Godsk
Galatius, Søren
Pedersen, Sune
Iversen, Allan
Biering-Sørensen, Tor
Funding for this research was provided by:
Copenhagen University
Article History
Received: 19 March 2024
Accepted: 23 July 2024
First Online: 3 August 2024
Declarations
:
: K.G.S: Advisory Board: Sanofi Pasteur.T.B-S: Steering Committee member of the Amgen financed GALACTIC-HF trial.Steering Committee member of the Boehringer Ingelheim financed SHARP3 trial.Chief investigator of the Sanofi Pasteur financed “NUDGE-FLU” trial.Chief investigator of the Sanofi Pasteur financed “DANFLU-1” trial.Chief investigator of the Sanofi Pasteur financed “DANFLU-2” trial.Steering Committee member of “LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific’s Investigational ICM System” trial.Advisory Board: Sanofi Pasteur, Amgen and GSK.Speaker Honorarium: Bayer, Novartis, Sanofi Pasteur and GSK.Research grants: GE Healthcare, AstraZeneca, Novo Nordisk and Sanofi Pasteur.The remaining others have no potential conflicts of interest to declare.
: The authors declare no competing interests.